Delhi Daily NewsFDA nod to Durata drug for acute skin infectionsDelhi Daily NewsThe Food and Drug Administration (FDA) has granted approval to Dalvance (dalbavancin), Durata Therapeutics’ drug for treating severe skin infections as well as skin structure ailments or ABSSSI. FDA nod to Durata drug for acute skin infections. According to …New Drug Dalvance Wins FDA Approval to Treat Skin InfectionsScience World ReportFDA Approves Durata Drug to Treat Acute Skin InfectionsNature World NewsFDA Approves New Antibiotic for Skin InfectionsABC NewsReutersall 58 news articles …Read Full Story
FDA nod to Durata drug for acute skin infections - Delhi Daily News
Real Estate of Cebu
